Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 60 Years to 90 Years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
The goal of this clinical trial is to determine if utilizing the Quest AD-Detect blood test, while patient's are hospitalized for a cognitive diagnosis (such as delirium or encephalopathy), will result in an earlier diagnosis of underlying Alzheimer's disease. * Will this blood test have the ability to distinguish between Alzheimer's disease and other causes of cognitive impairment in the inpatient setting? * Neurology Clinic will complete a 6-month post-hospitalization follow up with patients who have had the Quest AD-Detect Alzheimer's Disease blood test completed while they were inpatient to discuss the risk assessment portfolio
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Official eligibility criteria
Inclusion Criteria: * Ages 60 to 90 years old * No prior diagnosis of dementia * Currently hospitalized with cognitive diagnosis, including but no limited to; delirium, encephalopathy, etc. thought to be secondary to a toxic/metabolic state Exclusion Criteria: * Age under 60 years * Prior diagnosis of dementing illness or other organic etiology to cognitive impairment
Study sites (6)
TN
- Cumberland Medical Center · Crossville, TN 38555Clinical Research Nurse Coordinator · Study contact · 865-331-1337 · aholt10@covhlth.comSamuel A. Moore, MD · Principal investigatorMore trials in Crossville
- Roane Medical Center · Harriman, TN 37748Clinical Research Nurse Coordinator · Study contact · 865-331-1337 · aholt10@covhlth.comSamuel A. Moore, MD · Principal investigatorMore trials in Harriman
- Fort Sanders Regional Medical Center · Knoxville, TN 37916Clinical Research Nurse Coordinator · Study contact · 865-331-1337 · aholt10@covhlth.comSamuel A. Moore, MD · Principal investigatorMore trials in Knoxville
- Fort Loudon Medical Center · Lenoir City, TN 37772Clinical Research Nurse Coordinator · Study contact · 865-331-1337 · aholt10@covhlth.comSamuel A. Moore, MD · Principal investigatorMore trials in Lenoir City
- Methodist Medical Center · Oak Ridge, TN 37830Clinical Research Nurse Coordinator · Study contact · 865-331-1337 · aholt10@covhlth.comSamuel A. Moore, MD · Principal investigatorMore trials in Oak Ridge
- LeConte Medical Center · Sevierville, TN 37862Clinical Research Nurse Coordinator · Study contact · 865-331-1337 · aholt10@covhlth.comSamuel A. Moore, MD · Principal investigatorMore trials in Sevierville